TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Craniofacial morphology variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary intermolar distance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mandibular intermolar distance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in illness perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased understanding of vulvar symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: circulating tumor cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: tumor-to-contralateral breast ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Alleviation of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RC18 and RC18-BLyS complex profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient and observer scar assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient and observer overall opinion score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient and observer total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of large artery and small vessel ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Change in etiological diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in leadership activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Leading a new quality improvement initiative
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Career plans for the next five years
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: engagement in exercise referral schemes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maintenance of positive lifestyle behaviours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feasibility rate of RIT
Endpoint domain: Resource use
Primary endpoint: proportion of EHS 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Relationship score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: dimension of the augmented hard tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High EPDS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Benefit from extended letrozole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: yang‐deficiency quality scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FSS scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: attack times of exopathogenic diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Running-Related Injuries (RRIs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-breast tumor recurrence (IBTR) rate
Endpoint domain: Mortality/survival
Primary endpoint: resilience score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year patient survival estimate
Endpoint domain: Mortality/survival
Primary endpoint: complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: combined death or worsening heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: ICD shocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atrial Fibrillation (AF) status at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: QoR-15 score within 48 h after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cumulative use of patient‐controlled intravenous analgesia (PCIA) drugs at 24 h
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dietary feeding practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifestyle changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean time in range (TIR) 70‐180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of JPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in upper cervical mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ARR (Annualized Relapse Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased time to relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived anxiety and depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: elevation in total antioxidant capacity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intensity of postoperative inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Youth engagement with the program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Caregiver engagement with the program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: CDAI 100 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in prostate-specific antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPPB effect size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of heavy bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delirium incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Screening failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maintenance of target hemoglobin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: improved Left Ventricular Ejection Fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increased sensitivity to insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neutralising antibody seroconversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: duration of the active labor phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pan-Ig seroresponse rates (SRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBGA responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Success of medical management of EPL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight of neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motivation to alter dietary behaviours
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in cleaning performance of bedroom FTPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious adverse event (SAE) rate
Endpoint domain: Adverse events/effects
Primary endpoint: use of effective contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptability of effective contraception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Out-of-pocket (OOP) costs for hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Catastrophic health expenditures
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Membership in the suboptimal adherence group
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased interest in nutritional care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time and invasiveness of vestibuloplasty surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: comfort for the patient
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: predictable clinical result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke at 7 days
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of DHSU-PATF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MoCA-K scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ADAS-K-cog scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of Pap smears at 12-week follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infection within 30 days following vaginal delivery
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of adults with sufficient MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative minutes of MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy lifestyle practices
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mAging attenuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in the number of regular prescriptions at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in 28-days medication cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: attention/processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: end-tidal CO2 (EtCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiologic Partial Response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desensitization success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successfully consumed dose change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived driving certainty
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of wrong choices of gate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Driving time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post vaccination geometric mean titer (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean fold-rise in antibody response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of Oral Mucositis (OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity of NAD(P)-dependent dehydrogenases in peripheral blood lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FACT-BRM TOI score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: lymphedema-free rates
Endpoint domain: Mortality/survival
Primary endpoint: Modified Gloucester comfort score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of orthoptic exercises for IXT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fistula incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKDC scores at 9 months postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Signal intensity ratio of the ACL graft at 3 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of successful first-attempt cannulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Access time for femoral artery cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hypertension risk associated with SNP rs6770663
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proteinuria risk associated with SNP rs339947
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: EBP skills enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of decrease in brain parenchymal fraction (BPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of providing patient navigation services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Negative opioid urine test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OAHI reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate BP achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advanced adenoma discovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cancer discovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sodium Urinary Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Expression of active form of β‐catenin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of active/total form of β‐catenin protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nocturnal heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improving access to mental healthcare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feasibility and acceptability of the behavioral symptom management program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: policy awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: policy support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 'Everyday' food purchases
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Timed Up and Go Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of timolol in reducing epistaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of timolol treatment
Endpoint domain: Adverse events/effects
Primary endpoint: lengths of intensive care unit stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: PTA score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SRT score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WRS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of polyps per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nutritional indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival at 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Elevated ALT and AST levels
Endpoint domain: Adverse events/effects
Primary endpoint: quadriceps muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease from baseline in mean SF subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage decrease from baseline RB subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved SF ≤1 and RB = 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in height of fixed anatomical point postintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ATRS scores at two years
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of opioid medication shortages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of unused opioids left in homes after hospice home deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum respiratory oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of activation clusters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total MADRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour average cough count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cough-specific quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ameliorating pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increasing strength of TrA musculature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improving overall QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction of negative thoughts in mothers with PPD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: death, rehospitalization, or stroke at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Iatrogenic complications of jugular venous catheterization
Endpoint domain: Adverse events/effects
Primary endpoint: Heart rate variability data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause mortality or nonfatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: postsurgical pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid analgesics consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: antiemetics consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: μSBS mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distant Relapse-Free Survival (DRFS)
Endpoint domain: Mortality/survival
Primary endpoint: sensitivity of strabismus detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of strabismus detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worsening heart failure events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Kansas City Cardiomyopathy Questionnaire total symptom score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median time-to-first occurrence of CH attack reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in frequency of weekly pooled acute medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients achieving a 43% reduction in CH attacks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of monthly moderate-to-severe migraine headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of monthly severe migraine headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of migraine headache days with migraine-associated symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause mortality or non-fatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: knee instability concerns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance to gap formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Probability of ESL withdrawal
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: improvements in skin quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Progression of root resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes